On the public citation graph

Recent advancements in esophageal cancer treatment in Japan

https://doi.org/10.1002/ags3.12174
0 signed · 130 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.281.17.1623openalex-snapshot
Chemoradiotherapy of Locally Advanced Esophageal Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2017.1598openalex-snapshot
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer
inferredcites →https://doi.org/10.1002/14651858.cd010511.pub2openalex-snapshot
Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer
inferredcites →https://doi.org/10.1002/ags3.12174openalex-snapshot
Recent advancements in esophageal cancer treatment in Japan
inferredcites →https://doi.org/10.1002/bjs.10307openalex-snapshot
Impact of hospital volume on risk-adjusted mortality following oesophagectomy in Japan
inferredcites →https://doi.org/10.1002/bjs.9839openalex-snapshot
Variations in survival and perioperative complications between hospitals based on data from two phase III clinical trials for oesophageal cancer
inferredcites →https://doi.org/10.1002/cam4.1250openalex-snapshot
Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database
inferredcites →https://doi.org/10.1007/s00101-016-0179-yopenalex-snapshot
Perioperatives Management der transthorakalen Ösophagektomie
inferredcites →https://doi.org/10.1007/s00280-010-1422-xopenalex-snapshot
A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy
inferredcites →https://doi.org/10.1007/s00280-014-2597-3openalex-snapshot
A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy
inferredcites →https://doi.org/10.1007/s00280-016-2985-yopenalex-snapshot
Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
inferredcites →https://doi.org/10.1007/s00464-003-8181-2openalex-snapshot
Mediastinoscope-assisted transhiatal esophagectomy for esophageal cancer
inferredcites →https://doi.org/10.1007/s10120-016-0636-yopenalex-snapshot
Institutional variation in short- and long-term outcomes after surgery for gastric or esophagogastric junction adenocarcinoma: correlative study of two randomized phase III trials (JCOG9501 and JCOG9502)
inferredcites →https://doi.org/10.1007/s10147-018-1239-xopenalex-snapshot
A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma
inferredcites →https://doi.org/10.1007/s10388-016-0551-7openalex-snapshot
Japanese Classification of Esophageal Cancer, 11th Edition: part I
inferredcites →https://doi.org/10.1007/s11748-013-0246-0openalex-snapshot
Treatments for esophageal cancer: a review
inferredcites →https://doi.org/10.1016/j.bpg.2017.09.002openalex-snapshot
Alcohol, smoking and risk of oesophago-gastric cancer
inferredcites →https://doi.org/10.1016/j.clnu.2015.08.010openalex-snapshot
A systematic review of the nutritional consequences of esophagectomy
inferredcites →https://doi.org/10.1016/j.ejca.2015.05.027openalex-snapshot
Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone
inferredcites →https://doi.org/10.1016/j.ejca.2016.11.031openalex-snapshot
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
inferredcites →https://doi.org/10.1016/j.ejca.2017.04.027openalex-snapshot
Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial
inferredcites →https://doi.org/10.1016/j.jamcollsurg.2015.12.003openalex-snapshot
Prevention of Postoperative Venous Thromboembolism in Thoracic Surgical Patients: Implementation and Evaluation of a Caprini Risk Assessment Protocol
inferredcites →https://doi.org/10.1016/j.suronc.2017.09.003openalex-snapshot
Predictive biomarkers for response of esophageal cancer to chemo(radio)therapy: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/s0959-8049(97)00088-9openalex-snapshot
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
inferredcites →https://doi.org/10.1016/s1470-2045(15)00040-6openalex-snapshot
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
inferredcites →https://doi.org/10.1016/s1470-2045(16)30369-2openalex-snapshot
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer
inferredcites →https://doi.org/10.1016/s1470-2045(17)30043-8openalex-snapshot
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial
inferredcites →https://doi.org/10.1016/s1470-2045(17)30181-xopenalex-snapshot
Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial
inferredcites →https://doi.org/10.1016/s1470-2045(17)30447-3openalex-snapshot
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
inferredcites →https://doi.org/10.1038/nature20805openalex-snapshot
Integrated genomic characterization of oesophageal carcinoma
inferredcites →https://doi.org/10.1038/s41598-017-05278-0openalex-snapshot
Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia
inferredcites →https://doi.org/10.1038/sj.bjc.6603585openalex-snapshot
Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer
inferredcites →https://doi.org/10.1053/j.seminoncol.2005.04.005openalex-snapshot
Docetaxel in the Treatment of Esophageal Cancer
inferredcites →https://doi.org/10.1056/nejm199206113262403openalex-snapshot
Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus
inferredcites →https://doi.org/10.1056/nejmoa1709030openalex-snapshot
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1711948openalex-snapshot
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
inferredcites →https://doi.org/10.1093/annonc/mdw423openalex-snapshot
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
inferredcites →https://doi.org/10.1093/dote/dox047openalex-snapshot
Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer
inferredcites →https://doi.org/10.1093/dote/dox098openalex-snapshot
Fully robotic da Vinci Ivor–Lewis esophagectomy in four-arm technique—problems and solutions
inferredcites →https://doi.org/10.1093/dote/dox110openalex-snapshot
Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer—a narrative review
inferredcites →https://doi.org/10.1093/dote/dox114openalex-snapshot
The long-term effects of early oral feeding following minimal invasive esophagectomy
inferredcites →https://doi.org/10.1093/jjco/hye090openalex-snapshot
Phase II Evaluation of Protracted Infusion of Cisplatin and 5-Fluorouracil in Advanced Squamous Cell Carcinoma of the Esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407)
inferredcites →https://doi.org/10.1093/jjco/hyn064openalex-snapshot
Trend in Incidence of Adenocarcinoma of the Esophagus in Japan, 1993-2001
inferredcites →https://doi.org/10.1093/jjco/hyt061openalex-snapshot
Three-arm Phase III Trial Comparing Cisplatin Plus 5-FU (CF) Versus Docetaxel, Cisplatin Plus 5-FU (DCF) Versus Radiotherapy with CF (CF-RT) as Preoperative Therapy for Locally Advanced Esophageal Cancer (JCOG1109, NExT Study)
inferredcites →https://doi.org/10.1093/jjco/hyv012openalex-snapshot
A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study…
inferredcites →https://doi.org/10.1093/jjco/hyv120openalex-snapshot
A Phase III study of oral steroid administration versus local steroid injection therapy for the prevention of esophageal stricture after endoscopic submucosal dissection (JCOG1217, Steroid EESD P3)
inferredcites →https://doi.org/10.1093/jjco/hyv178openalex-snapshot
A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409
inferredcites →https://doi.org/10.1093/jjco/hyx040openalex-snapshot
Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A)
inferredcites →https://doi.org/10.1093/oxfordjournals.jjco.a039543openalex-snapshot
Phase II Evaluation of Cisplatin and 5-Fluorouracil in Advanced Squamous Cell Carcinoma of the Esophagus: A Japanese Esophageal Oncology Group Trial
inferredcites →https://doi.org/10.1097/jto.0000000000000612openalex-snapshot
Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus
inferredcites →https://doi.org/10.1097/jto.0b013e3181c1ffd5openalex-snapshot
Phase I/II Study of Docetaxel/Cisplatin/Fluorouracil Combination Chemotherapy Against Metastatic Esophageal Squamous Cell Carcinoma
inferredcites →https://doi.org/10.1097/mcg.0000000000000790openalex-snapshot
Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer
inferredcites →https://doi.org/10.1097/md.0000000000007436openalex-snapshot
Effect of perioperative oral care on prevention of postoperative pneumonia associated with esophageal cancer surgery
inferredcites →https://doi.org/10.1097/md.0000000000007944openalex-snapshot
Diabetes mellitus carries a risk of esophageal cancer
inferredcites →https://doi.org/10.1097/sla.0000000000002252openalex-snapshot
Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer
inferredcites →https://doi.org/10.1097/sla.0000000000002280openalex-snapshot
Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma
inferredcites →https://doi.org/10.1097/sla.0000000000002304openalex-snapshot
Early Oral Feeding Following McKeown Minimally Invasive Esophagectomy
inferredcites →https://doi.org/10.1111/ases.12437openalex-snapshot
Robotic surgery for the upper gastrointestinal tract: Current status and future perspectives
inferredcites →https://doi.org/10.1111/cas.12274openalex-snapshot
Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma
inferredcites →https://doi.org/10.1111/cas.12486openalex-snapshot
Phase I/ II trial of 2‐weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer ( JCOG 0807)
inferredcites →https://doi.org/10.1111/cas.12943openalex-snapshot
Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma
inferredcites →https://doi.org/10.1111/dote.12381openalex-snapshot
Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma
inferredcites →https://doi.org/10.1111/jgh.13153openalex-snapshot
Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-16-0292openalex-snapshot
New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints
inferredcites →https://doi.org/10.1159/000329806openalex-snapshot
Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Esophagus
inferredcites →https://doi.org/10.1159/000446361openalex-snapshot
Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy
inferredcites →https://doi.org/10.1159/000481223openalex-snapshot
Clinical Analysis of Esophageal Stricture in Patients Treated with Intralesional Triamcinolone Injection after Endoscopic Submucosal Dissection for Superficial Esophageal Cancer
inferredcites →https://doi.org/10.1186/s12885-017-3542-8openalex-snapshot
Physical ExeRcise Following Esophageal Cancer Treatment (PERFECT) study: design of a randomized controlled trial
inferredcites →https://doi.org/10.1200/jco.2005.00.034openalex-snapshot
Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the Esophagus
inferredcites →https://doi.org/10.1200/jco.2005.04.7118openalex-snapshot
Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102
inferredcites →https://doi.org/10.1200/jco.2005.23.16_suppl.8547openalex-snapshot
The clinical relevance of telomerase activity and telomere length in pediatric solid tumors
inferredcites →https://doi.org/10.1200/jco.2015.62.6598openalex-snapshot
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial
inferredcites →https://doi.org/10.1200/jco.2017.74.9846openalex-snapshot
Safety and Antitumor Activity of the Anti–Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma
inferredcites →https://doi.org/10.1245/s10434-011-2049-9openalex-snapshot
A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
inferredcites →https://doi.org/10.1245/s10434-014-3684-8openalex-snapshot
Outcomes of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Esophagectomy in Patients with Resectable Node-Positive Esophageal Cancer
inferredcites →https://doi.org/10.1245/s10434-015-4767-xopenalex-snapshot
A Prospective Randomized Trial of Enteral Nutrition After Thoracoscopic Esophagectomy for Esophageal Cancer
inferredcites →https://doi.org/10.1245/s10434-017-5808-4openalex-snapshot
Comparison of Short-Term Outcomes Between Open and Minimally Invasive Esophagectomy for Esophageal Cancer Using a Nationwide Database in Japan
inferredcites →https://doi.org/10.1371/journal.pone.0110348openalex-snapshot
Esophageal Adenocarcinoma and Its Rare Association with Barrett’s Esophagus in Henan, China
inferredcites →https://doi.org/10.2196/resprot.7688openalex-snapshot
Immune-Enhancing Formulas for Patients With Cancer Undergoing Esophagectomy: Systematic Review Protocol
inferredcites →https://doi.org/10.3727/096504016x14618564639213openalex-snapshot
Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4680849openalex-extracted
inferred← citeshttps://doi.org/10.1002/ags3.12394openalex-snapshot
Efficacy of intraoperative recurrent laryngeal neuromonitoring during surgery for esophageal cancer
inferred← citeshttps://doi.org/10.1002/ags3.12444openalex-snapshot
Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature
inferred← citeshttps://doi.org/10.1002/ags3.12693openalex-snapshot
Anatomical and anastomotic viability indexes for stratifying the risk of anastomotic leakage in esophagectomy with retrosternal reconstruction
inferred← citeshttps://doi.org/10.1002/ags3.12706openalex-snapshot
Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer
inferred← citeshttps://doi.org/10.1007/s00280-024-04737-6openalex-snapshot
Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer
inferred← citeshttps://doi.org/10.1007/s00423-020-02053-0openalex-snapshot
Management and outcomes of resectable gastric conduit cancer: a retrospective comparative study of 51 cases
inferred← citeshttps://doi.org/10.1007/s10147-018-1239-xopenalex-snapshot
A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma
inferred← citeshttps://doi.org/10.1007/s10147-023-02428-5openalex-snapshot
Clinical impact of diarrhea during enteral feeding after esophagectomy
inferred← citeshttps://doi.org/10.1007/s10388-020-00782-1openalex-snapshot
Multimodality approaches to control esophageal cancer: development of chemoradiotherapy, chemotherapy, and immunotherapy
inferred← citeshttps://doi.org/10.1007/s10388-022-00920-xopenalex-snapshot
First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590
inferred← citeshttps://doi.org/10.1007/s10388-023-01013-zopenalex-snapshot
Prognostic impact of perioperative change in serum p53 antibody titers in esophageal squamous cell carcinoma
inferred← citeshttps://doi.org/10.1007/s10388-024-01084-6openalex-snapshot
Validation of the cutoff values for the number of metastatic lymph nodes for esophageal cancer staging: a multi-institutional analysis of 655 patients in Japan
inferred← citeshttps://doi.org/10.1007/s11748-019-01070-1openalex-snapshot
Efficacy of preserving the residual stomach in esophageal cancer patients with previous gastrectomy
inferred← citeshttps://doi.org/10.1007/s11748-023-02006-6openalex-snapshot
Identifying intense inflammatory subtype of esophageal squamous cell carcinoma using clustering approach
inferred← citeshttps://doi.org/10.1007/s12328-023-01792-zopenalex-snapshot
A case of advanced hypopharyngeal cervical esophageal cancer treated by curative resection with management of tracheoesophageal fistula
inferred← citeshttps://doi.org/10.1016/j.actbio.2018.10.035openalex-snapshot
3D-printed flexible polymer stents for potential applications in inoperable esophageal malignancies
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e28070openalex-snapshot
Probiotic-derived ferrichrome induces DDIT3-mediated antitumor effects in esophageal cancer cells
inferred← citeshttps://doi.org/10.1016/j.isci.2026.114638openalex-snapshot
Patient-derived organoid xenografts model esophageal cancer cachexia and enable assessment of anti-inflammatory drug repositioning
inferred← citeshttps://doi.org/10.1016/j.prp.2019.152601openalex-snapshot
Significant association between 53 BP1 expression and grade of intraepithelial neoplasia of esophagus: Alteration during esophageal carcinogenesis
inferred← citeshttps://doi.org/10.1016/j.suc.2019.02.004openalex-snapshot
Combined Modality Therapy for Management of Esophageal Cancer
inferred← citeshttps://doi.org/10.1038/s10038-020-0795-xopenalex-snapshot
RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation
inferred← citeshttps://doi.org/10.1093/dote/doz051openalex-snapshot
Surgery to the primary tumor is associated with improved survival of patients with metastatic esophageal cancer: propensity score-matched analyses of a large retrospective cohort
inferred← citeshttps://doi.org/10.1097/rc9.0000000000000353openalex-snapshot
Eight-year patient survival following multidisciplinary management for two recurrences of esophageal cancer: case report and literature review
inferred← citeshttps://doi.org/10.1111/cas.15350openalex-snapshot
Novel cancer‐specific epidermal growth factor receptor antibody obtained from the serum of esophageal cancer patients with long‐term survival
inferred← citeshttps://doi.org/10.1115/1.4065906openalex-snapshot
The Development of a Novel Peristaltic Test Stand “Swallow-Sim” for the Mechanical Evaluation of Esophageal Stents
inferred← citeshttps://doi.org/10.1177/0300891620960223openalex-snapshot
Development of chimeric antigen receptor-modified T cells for the treatment of esophageal cancer
inferred← citeshttps://doi.org/10.1590/0102-672020190001e1475openalex-snapshot
TRANSHIATAL ESOPHAGECTOMY IS NOT ASSOCIATED WITH POOR QUALITY LYMPHADENECTOMY
inferred← citeshttps://doi.org/10.1634/theoncologist.2018-0653openalex-snapshot
Phase II Trial of 5-Fluorouracil, Docetaxel, and Nedaplatin (UDON) Combination Therapy for Recurrent or Metastatic Esophageal Cancer
inferred← citeshttps://doi.org/10.1634/theoncologist.2019-0641openalex-snapshot
Antitumor Activity of Larotrectinib in Esophageal Carcinoma withNTRKGene Amplification
inferred← citeshttps://doi.org/10.21037/apm.2019.09.07openalex-snapshot
Comparison of esophageal stent placement versus endoscopic incision method for treatment of refractory esophageal anastomotic stricture
inferred← citeshttps://doi.org/10.21873/invivo.11730openalex-snapshot
Combination Therapy With S-1, Oxaliplatin and Leucovorin in Patients With Advanced Esophageal Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.21873/invivo.13443openalex-snapshot
Clinical Significance of Prealbumin Level Measurement Before Neoadjuvant Chemotherapy in Elderly Patients With Locally Advanced Esophageal Cancer
inferred← citeshttps://doi.org/10.24171/j.phrp.2019.10.4.08openalex-snapshot
Cell Death Mechanisms in Esophageal Squamous Cell Carcinoma Induced by Vesicular Stomatitis Virus Matrix Protein
inferred← citeshttps://doi.org/10.3389/fonc.2021.666340openalex-snapshot
Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies
inferred← citeshttps://doi.org/10.3390/biom15081128openalex-snapshot
The Role of Mitochondrial DNA in Modulating Chemoresistance in Esophageal Cancer: Mechanistic Insights and Therapeutic Potential
inferred← citeshttps://doi.org/10.3390/biomimetics9060359openalex-snapshot
Innovative Design of a 3D Printed Esophageal Stent Inspired by Nature: Mitigating Migration Challenges in Palliative Esophageal Cancer Therapy
inferred← citeshttps://doi.org/10.3390/cancers13010141openalex-snapshot
Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries
inferred← citeshttps://doi.org/10.3390/cells10051055openalex-snapshot
Development of a Decellularized Porcine Esophageal Matrix for Potential Applications in Cancer Modeling
inferred← citeshttps://doi.org/10.3390/curroncol33060353openalex-snapshot
Association Between Thoracic Inlet Size and Cervical Anastomosis Outcomes in Esophageal Cancer Surgery
inferred← citeshttps://doi.org/10.3390/nano9111548openalex-snapshot
Biocompatible Polymer Materials with Antimicrobial Properties for Preparation of Stents
inferred← citeshttps://doi.org/10.3390/ncrna8060080openalex-snapshot
SOX2OT lncRNA Inhibition Suppresses the Stemness Characteristics of Esophageal Tumorspheres
inferred← citeshttps://doi.org/10.3919/jjsa.80.707openalex-snapshot
A Case of Pathologic Complete Response with Neoadjuvant Biweekly-DCF Therapy and following Laparoscopic Transhiatal Extended Total Gastrectomy for Advanced Esophagogastric Junction Adenocarcinoma
inferred← citeshttps://doi.org/10.3923/ijp.2024.552.560openalex-snapshot
Long Non-Coding RNA MAFG-AS1 Regulates the Proliferation and Epithelial to Mesenchymal Transition of Human Esophageal Carcinoma Cells
inferred← citeshttps://doi.org/10.52547/mlj.15.2.23openalex-snapshot
Docetaxel Toxicity Optimization in Esophageal Squamous Cell Carcinoma Cell Line YM-1: A Study of Cell Cycle and Doubling Time Effect
inferred← citeshttps://doi.org/10.7287/peerj.9294v0.1/reviews/1openalex-snapshot
Peer Review #1 of "Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma (v0.1)"
inferred← citeshttps://doi.org/10.7287/peerj.9294v0.1/reviews/2openalex-snapshot
Peer Review #2 of "Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma (v0.1)"
inferred← citeshttps://doi.org/10.7287/peerj.9294v0.2/reviews/1openalex-snapshot
Peer Review #1 of "Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma (v0.2)"
inferred← citeshttps://doi.org/10.7717/peerj.9294openalex-snapshot
Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma
showing the first 49 of 50 · page through all 50
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.